Showing 1 - 20 results of 10,517 for search '(( significantly improved decrease ) OR ( significant ((we decrease) OR (small decrease)) ))', query time: 0.48s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

    Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

    Published 2025
    “…Ruxolitinib, a JAK/STAT inhibitor, has been shown to improve cutaneous manifestations of SLE. We hypothesize that the addition of ruxolitinib to UCB-Tregs may improve SLE outcomes.…”
  6. 6

    Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

    Published 2025
    “…Ruxolitinib, a JAK/STAT inhibitor, has been shown to improve cutaneous manifestations of SLE. We hypothesize that the addition of ruxolitinib to UCB-Tregs may improve SLE outcomes.…”
  7. 7

    Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

    Published 2025
    “…Ruxolitinib, a JAK/STAT inhibitor, has been shown to improve cutaneous manifestations of SLE. We hypothesize that the addition of ruxolitinib to UCB-Tregs may improve SLE outcomes.…”
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14

    YOLO11. by Junyan Wang (4738518)

    Published 2025
    Subjects:
  15. 15
  16. 16
  17. 17
  18. 18

    SCI-YOLO11. by Junyan Wang (4738518)

    Published 2025
    Subjects:
  19. 19
  20. 20

    YOLOV8. by Junyan Wang (4738518)

    Published 2025
    Subjects: